Fujirebio expands its assay menu in the field of neurodegene

H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G NfL CSF and Lumipulse G NfL Blood assays for the fully automated random-access LUMIPULSE

Related Keywords

Fujirebio Europe , Christiaan De Wilde , Zetterbergh Neurofilament , Public Relations Sustainability Department , Research Use , Hu Group Holdings Inc , Lumipulseg Nfl , Lumipulseg Nfl Blood , Global Head Neuro , Holdings Inc , Neuro Filament Proteins , Cold Spring Harb Perspect , Neurol Neurosurg , Neurofilament Light Chain , Monitor Neurological Diseases , Relations Section , Sustainability Department , Fujirebio , Xpands , Essay , Menu , Field , Neurodegenerative , Diseases , Launch , Bully , Utomated , Umipulse , Flood , Tests ,